...focus: Infectious Clinical status: Preclinical Founded: 2017 by Leah Cowen, Luke Whitesell, Schrödinger LLC and MaRS Innovation... ...Corporate partners: Schrödinger LLC Number of employees: Undisclosed Funds raised: C$1 million ($0.75 million) Investors: MaRS Innovation... ...Therapeutics Inc., Toronto, Ont. F2G Ltd., Eccles, U.K. Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL), West Conshohocken, Pa. MaRS Innovation...
...In September, MaRS Innovation (Toronto, Ontario) and Evotec AG (Xetra:EVT) partnered to open the Toronto-based LAB150 accelerator... ...shorten the drug discovery timeline by designating $75,000-$400,000 to 3-5 projects a year emerging from MaRS innovation’s... ...by the accelerator. Evotec AG (Xetra:EVT), Hamburg, Germany MaRS Innovation , Toronto, Ontario Business: Pharmaceuticals
Alicia Parker
Evotec AG
MaRS Innovation...
...in healthy individuals and Type I diabetes patients. The newco spun out of CDRD and MaRS Innovation... ...Technology: Somatostatin receptor 2 (SSTR2) antagonists Disease focus: Endocrine/metabolic Clinical status: Preclinical Founded: 2014 by MaRS Innovation... ...of Toronto Corporate partners: None Number of employees: 5 Funds raised: $2 million Investors: CDRD, MaRS Innovation...
...hypoglycemia in patients with Type I diabetes. Zucara is a 2015 spinout of CDRD and MaRS Innovation... ...Research in Immunology and Cancer - Commercialization of Research (IRICoR) projects co-developed with CDRD or MaRS Innovation...
...spring 2016. J&J is launching the incubator in collaboration with the University of Toronto , MaRS Innovation... ...Ministry of Economic Development, Employment and Infrastructure. In June, J&J expanded an existing collaboration with MaRS Innovation...
...The key difference between the two regions, he said, is lab space. Whereas Toronto has MaRS Innovation... ...Vancouver, B.C. Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France MaRS Innovation...
...focus: Infectious Clinical status: Preclinical Founded: 2017 by Leah Cowen, Luke Whitesell, Schrödinger LLC and MaRS Innovation... ...Corporate partners: Schrödinger LLC Number of employees: Undisclosed Funds raised: C$1 million ($0.75 million) Investors: MaRS Innovation... ...Therapeutics Inc., Toronto, Ont. F2G Ltd., Eccles, U.K. Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL), West Conshohocken, Pa. MaRS Innovation...
...In September, MaRS Innovation (Toronto, Ontario) and Evotec AG (Xetra:EVT) partnered to open the Toronto-based LAB150 accelerator... ...shorten the drug discovery timeline by designating $75,000-$400,000 to 3-5 projects a year emerging from MaRS innovation’s... ...by the accelerator. Evotec AG (Xetra:EVT), Hamburg, Germany MaRS Innovation , Toronto, Ontario Business: Pharmaceuticals
Alicia Parker
Evotec AG
MaRS Innovation...
...in healthy individuals and Type I diabetes patients. The newco spun out of CDRD and MaRS Innovation... ...Technology: Somatostatin receptor 2 (SSTR2) antagonists Disease focus: Endocrine/metabolic Clinical status: Preclinical Founded: 2014 by MaRS Innovation... ...of Toronto Corporate partners: None Number of employees: 5 Funds raised: $2 million Investors: CDRD, MaRS Innovation...
...hypoglycemia in patients with Type I diabetes. Zucara is a 2015 spinout of CDRD and MaRS Innovation... ...Research in Immunology and Cancer - Commercialization of Research (IRICoR) projects co-developed with CDRD or MaRS Innovation...
...spring 2016. J&J is launching the incubator in collaboration with the University of Toronto , MaRS Innovation... ...Ministry of Economic Development, Employment and Infrastructure. In June, J&J expanded an existing collaboration with MaRS Innovation...
...The key difference between the two regions, he said, is lab space. Whereas Toronto has MaRS Innovation... ...Vancouver, B.C. Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France MaRS Innovation...